Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

Thoracic sarcoidosis is the most common form of sarcoidosis, encompassing a
heterogeneous group of patients with a wide range of clinical features and associated …

The term “advanced sarcoidosis” is used for forms of sarcoidosis with a significant risk of
loss of organ function or death. Advanced sarcoidosis often involves the lung and is …

Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology. A minority of
patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which …

Sarcoidosis is a highly variable granulomatous multisystem syndrome. It affects individuals
in the prime years of life; both the frequency and severity of sarcoidosis are greater in …

Sarcoidosis, a multisystem granulomatous disorder, has historically been classified as Th1-
driven disease. However, increasing data demonstrate a key role of Th17-cell plasticity in …

The aim of this manuscript is to provide a comprehensive review of the etiology,
measurement, and treatment of common pulmonary symptoms associated with sarcoidosis …

Introduction Advanced pulmonary sarcoidosis refers to phenotypes of pulmonary
sarcoidosis that often lead to significant loss of lung function, respiratory failure, or death …

Although relatively few patients with pulmonary sarcoidosis develop advanced disease that
progresses to respiratory insufficiency despite receiving best practice pharmacologic …

Sarcoidosis is a multisystem disease of unknown cause with heterogeneous clinical
manifestations and variable course. Spontaneous remissions occur in some patients …